Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

MK-6837 is under clinical development by Merck and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...

Copper demand is expected to stay red-hot, according to Jorge Cantallopts, an executive director at the Center for Copper and ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. That is the view of UBS ...

Signals from the incoming administration indicate a possible focus on policy pivots that they believe will result in a more ...

As 2024 ends, India’s AI sector has transitioned from its experimentation stage to strategic adoption, primarily driven by ...

The war between Russia and Ukraine has now entered its 1044th day since starting on February 24, 2022. In this relatively short time, drones have become a bona fide tour de force on the battlefield.

When Gloria Kopp got fed up with diet after diet that just didn't work, she took the advice of a friend who'd slimmed down with a commercial diet plan called the Medi-Weightloss Program.

Northwestern this fall will become the newest site for Bottom Line, a nonprofit initiative that gives students from ...

Street photographer Christopher Ward has amassed more than a million followers by capturing the wisdom of strangers in ...

THISDAY has honoured D’Tigress as Sports Personality of the Year and unveiled nominees for Game Changer and Lifetime Achievements categories ...